Nucleic Acids Research, 1988, Vol. 16, No. 22 10699-10716
© 1988
ENZYMOLOGY |
An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene
1International Institute of Genetics and Biophysics CNR, Naples, Italy 2Institute for Cancer Research, Columbia University New York, NY, USA 3Mikrobiologisk Institut, University of Copenhagen Denmark 4Lepetit SpA Research Laboratories Gerenzano, Italy
To whom correspondence should be addressed at: Mikrobiology Institut, Oster Farimagsgade 2A, 1353 Copenhagen K. Denmark
Received July 27, 1988. Revised September 29, 1988. Accepted October 24, 1988.
The 5' flanking region of the human urokinase (uPA) gene has been fused to the reporter chloramphenicol acetyl transferase (CAT) gene and its activity assayed by transfection in two human cell lines. Progressive deletions of the uPA regulatory region from the 5' end maintain a high level of expression provided at least 1870 (in A1251 cells) or 1963 (in HFS10cells) nucleotides of the 5' flanking region are retained. A DNA fragment from –2350 to –1824 has enhancer properties, stimulating transcription of an enhancerless SV40 early promoter independently of orientation and distance. Internal deletions of that still retain the enhancer element reveal the presence of negative cis-acting sequences between –1824 and –1572. Their removal, in fact, increases uPA transcriptional activity. Differences ofexpression of the uPA-CAT fusion genes in the two cell lines are also observed, indicating the presence of cell-specific cis-acting sequences.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Diefenbacher, S. Sekula, C. Heilbock, J. V. Maier, M. Litfin, H. van Dam, M. Castellazzi, P. Herrlich, and O. Kassel Restriction to Fos Family Members of Trip6-Dependent Coactivation and Glucocorticoid Receptor-Dependent Trans-Repression of Activator Protein-1 Mol. Endocrinol., August 1, 2008; 22(8): 1767 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ferrai, D. Munari, P. Luraghi, L. Pecciarini, M. G. Cangi, C. Doglioni, F. Blasi, and M. P. Crippa A Transcription-dependent Micrococcal Nuclease-resistant Fragment of the Urokinase-type Plasminogen Activator Promoter Interacts with the Enhancer J. Biol. Chem., April 27, 2007; 282(17): 12537 - 12546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-Y. Bao, S.-D. Yeh, and Y.-F. Lee 1{alpha},25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases Carcinogenesis, January 1, 2006; 27(1): 32 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aljada, H. Ghanim, P. Mohanty, T. Syed, A. Bandyopadhyay, and P. Dandona Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations Am. J. Clinical Nutrition, July 1, 2004; 80(1): 51 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Benasciutti, G. Pages, O. Kenzior, W. Folk, F. Blasi, and M. P. Crippa MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription Blood, July 1, 2004; 104(1): 256 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pakneshan, B. Tetu, and S. A. Rabbani Demethylation of Urokinase Promoter as a Prognostic Marker in Patients with Breast Carcinoma Clin. Cancer Res., May 1, 2004; 10(9): 3035 - 3041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. PAKNESHAN, R. H. XING, and S. A. RABBANI Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo FASEB J, June 1, 2003; 17(9): 1081 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ibanez-Tallon, C. Ferrai, E. Longobardi, I. Facetti, F. Blasi, and M. P. Crippa Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells Blood, October 16, 2002; 100(9): 3325 - 3332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fu, J. Zhang, Y. Lin, X. Zhu, M. U. Ehrengruber, and Y. E. Chen Early Growth Response Factor-1 Is a Critical Transcriptional Mediator of Peroxisome Proliferator-activated Receptor-gamma 1 Gene Expression in Human Aortic Smooth Muscle Cells J. Biol. Chem., July 19, 2002; 277(30): 26808 - 26814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Finkelstein, R. Makkar, T. M. Doherty, V. R. Vegesna, P. Tripathi, M. Liu, J. Bergman, M. Fishbein, J. Hausleiter, K. Takizawa, et al. Increased Expression of Macrophage Colony-Stimulating Factor After Coronary Artery Balloon Injury Is Inhibited by Intracoronary Brachytherapy Circulation, May 21, 2002; 105(20): 2411 - 2415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shimada, Y. Suzuki, S.-J. Kim, P.-C. Wang, M. Matsumura, and S. Kojima Transactivation via RAR/RXR-Sp1 Interaction: Characterization of Binding Between Sp1 and GC Box Motif Mol. Endocrinol., October 1, 2001; 15(10): 1677 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Huang, L. New, Z. Pan, J. Han, and G. R. Nemerow Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38alpha Mitogen-activated Protein Kinase Activity J. Biol. Chem., April 14, 2000; 275(16): 12266 - 12272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Koli and J. Keski-Oja 1{{alpha}},25-Dihydroxyvitamin D3 and Its Analogues Down-Regulate Cell Invasion-associated Proteases in Cultured Malignant Cells Cell Growth Differ., April 1, 2000; 11(4): 221 - 229. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kojima, S. Hayashi, K. Shimokado, Y. Suzuki, J. Shimada, M. P. Crippa, and S. L. Friedman Transcriptional activation of urokinase by the Kruppel-like factor Zf9/COPEB activates latent TGF-beta 1 in vascular endothelial cells Blood, February 15, 2000; 95(4): 1309 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Silverman, L. M. Khachigian, F. S. Santiago, A. J. Williams, V. Lindner, and T. Collins Vascular Smooth Muscle Cells Express the Transcriptional Corepressor NAB2 in Response to Injury Am. J. Pathol., October 1, 1999; 155(4): 1311 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cirillo, L. Casalino, D. Vallone, A. Caracciolo, D. De Cesare, and P. Verde Role of Distinct Mitogen-Activated Protein Kinase Pathways and Cooperation between Ets-2, ATF-2, and Jun Family Members in Human Urokinase-Type Plasminogen Activator Gene Induction by Interleukin-1 and Tetradecanoyl Phorbol Acetate Mol. Cell. Biol., September 1, 1999; 19(9): 6240 - 6252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Xing and S. A. Rabbani Regulation of Urokinase Production by Androgens in Human Prostate Cancer Cells: Effect on Tumor Growth and Metastases in Vivo Endocrinology, September 1, 1999; 140(9): 4056 - 4064. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Suzuki, J. Shimada, K. Shudo, M. Matsumura, M. P. Crippa, and S. Kojima Physical Interaction Between Retinoic Acid Receptor and Sp1: Mechanism for Induction of Urokinase by Retinoic Acid Blood, June 15, 1999; 93(12): 4264 - 4276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ried, C. Jager, M. Jeffers, G. F. Vande Woude, H. Graeff, M. Schmitt, and E. Lengyel Activation Mechanisms of the Urokinase-type Plasminogen Activator Promoter by Hepatocyte Growth Factor/Scatter Factor J. Biol. Chem., June 4, 1999; 274(23): 16377 - 16386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mechtcheriakova, A. Wlachos, H. Holzmuller, B. R. Binder, and E. Hofer Vascular Endothelial Cell Growth Factor-Induced Tissue Factor Expression in Endothelial Cells Is Mediated by EGR-1 Blood, June 1, 1999; 93(11): 3811 - 3823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Silverman and T. Collins Pathways of Egr-1-Mediated Gene Transcription in Vascular Biology Am. J. Pathol., March 1, 1999; 154(3): 665 - 670. [Full Text] [PDF]
|
|
|
|
|
|
H. Allgayer, H. Wang, Y. Wang, M. M. Heiss, R. Bauer, O. Nyormoi, and D. Boyd Transactivation of the Urokinase-type Plasminogen Activator Receptor Gene through a Novel Promoter Motif Bound with an Activator Protein-2alpha -related Factor J. Biol. Chem., February 19, 1999; 274(8): 4702 - 4714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Dieckgraefe and D. M. Weems Epithelial injury induces Egr-1 and Fos expression by a pathway involving protein kinase C and ERK Am J Physiol Gastrointest Liver Physiol, February 1, 1999; 276(2): G322 - G330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Franco, O. Massa, M. Garcia-Rocha, F. Chiaradonna, C. Iaccarino, I. Correas, E. Mendez, J. Avila, F. Blasi, and M. P. Stoppelli Protein Kinase C-dependent in Vivo Phosphorylation of Prourokinase Leads to the Formation of a Receptor Competitive Antagonist J. Biol. Chem., October 16, 1998; 273(42): 27734 - 27740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Wilson, F. Vives, T. Collins, and H. E. Ives Strain-Responsive Regions in the Platelet-Derived Growth Factor-A Gene Promoter Hypertension, January 1, 1998; 31(1): 170 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Khachigian and T. Collins Inducible Expression of Egr-1–Dependent Genes : A Paradigm of Transcriptional Activation in Vascular Endothelium Circ. Res., October 19, 1997; 81(4): 457 - 461. [Full Text]
|
|
|
|
|
|
D. De Cesare, M. Palazzolo, J. Berthelsen, and F. Blasi Characterization of UEF-4, a DNA-binding Protein Required for Transcriptional Synergism between Two AP-1 Sites in the Human Urokinase Enhancer J. Biol. Chem., September 19, 1997; 272(38): 23921 - 23929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Silberman, M. Janulis, and R. M. Schultz Characterization of Downstream Ras Signals That Induce Alternative Protease-dependent Invasive Phenotypes J. Biol. Chem., February 28, 1997; 272(9): 5927 - 5935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gum, E. Lengyel, J. Juarez, J. H. Chen, H. Sato, M. Seiki, and D. Boyd Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences J. Biol. Chem., May 3, 1996; 271(18): 10672 - 10680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Berthelsen, J. Vandekerkhove, and F. Blasi Purification and Characterization of UEF3, A Novel Factor Involved in the Regulation of the Urokinase and Other AP-1 Controlled Promoters J. Biol. Chem., February 16, 1996; 271(7): 3822 - 3830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lengyel, E. Stepp, R. Gum, and D. Boyd Involvement of a Mitogen-activated Protein Kinase Signaling Pathway in the Regulation of Urokinase Promoter Activity by c-Ha-ras J. Biol. Chem., September 29, 1995; 270(39): 23007 - 23012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hapke, H. Kessler, N. A. de Prada, A. Benge, M. Schmitt, E. Lengyel, and U. Reuning Integrin alpha vbeta 3/Vitronectin Interaction Affects Expression of the Urokinase System in Human Ovarian Cancer Cells J. Biol. Chem., July 6, 2001; 276(28): 26340 - 26348. [Abstract] [Full Text] [PDF]
|
|